|
0
|
|
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial.
(nature.com)
|
Fedak RR
…
Jewell CM
Nature Medicine
2026-03-01
|
#transcriptomics
#immunotherapy
#biomarker
#autoimmune
#myasthenia gravis
|
|
0
|
|
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.
(nature.com)
|
Vu T
…
Howard JF Jr
Nature Medicine
2026-03-01
|
#clinical trial
#immunotherapy
#autoimmunity
#car t-cell
#myasthenia gravis
|
|
0
|
|
IDR-induced CAR condensation improves the cytotoxicity of CAR-Ts against low-antigen cancers.
(nature.com)
|
Zhang X
…
Su X
Nature Chemical Biology
2026-03-01
|
#cancer
#immunotherapy
#car-t
#engineering
#cytotoxicity
|
|
0
|
|
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.
(nature.com)
|
Hoeijmakers LL
…
Blank CU
Nature Medicine
2026-03-01
|
#immunotherapy
#melanoma
#biomarker
#neoadjuvant
#checkpoint inhibitor
|
|
0
|
|
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.
(nature.com)
|
Lee H
…
Bahlis NJ
Nature Medicine
2026-03-01
|
#amr
#transcriptomics
#cancer
#immunotherapy
#mutation
|
|
0
|
|
Analysis of microsatellite instability intensity in single-cell resolution with scMnT reveals tumor heterogeneity in colorectal cancer.
(academic.oup.com)
|
Park G
…
Park J
Briefings in Bioinformatics
2026-03-01
|
#immunotherapy
#single-cell
#heterogeneity
#colorectal cancer
#microsatellite
|
|
0
|
|
Engineering synthetic agonists for targeted activation of Notch signaling.
(nature.com)
|
Perez DH
…
Luca VC
Nature Chemical Biology
2026-03-01
|
#immunotherapy
#synthetic biology
#protein design
#cell signaling
|
|
0
|
|
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.
(nature.com)
|
D'Alise AM
…
Vilar E
Nature Medicine
2026-03-01
|
#vaccination
#immunity
#cancer
#immunotherapy
#neoantigen
|
|
0
|
|
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.
(nature.com)
|
Muller F
…
Schett G
Nature Medicine
2026-03-01
|
#clinical trial
#immunotherapy
#car-t
#autoimmune
#lupus
|
|
0
|
|
The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.
(nature.com)
|
Cheng H
…
Li G
Nature
2026-03-01
|
#immunity
#cancer
#immunotherapy
#proteostasis
#exhaustion
|
|
0
|
|
Microbiota-induced T cell plasticity enables immune-mediated tumour control.
(nature.com)
|
Najar TA
…
Littman DR
Nature
2026-03-01
|
#microbiome
#immunity
#cancer
#immunotherapy
#t cell
|
|
0
|
|
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein.
(nature.com)
|
George BM
…
Tzelepis K
Nature Biotechnology
2026-03-01
|
#antibody
#cancer
#immunotherapy
#biomarker
#leukemia
|
|
0
|
|
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.
(nature.com)
|
Becilli M
…
Locatelli F
Nature Medicine
2026-03-01
|
#immunotherapy
#car-t
#autoimmune
|
|
0
|
|
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.
(nature.com)
|
Sahin U
…
Tureci O
Nature
2026-03-01
|
#vaccination
#cancer
#immunotherapy
#neoantigen
#t cell
|
|
0
|
|
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.
(nature.com)
|
Yap TA
…
Gan L
Nature Medicine
2026-03-01
|
#pharmacokinetics
#cancer
#immunotherapy
#biomarker
#checkpoint_inhibition
|
|
0
|
|
A small molecule targets LIC1 to suppress lung tumor growth by inducing autophagy.
(nature.com)
|
Huang JL
…
Yin S
Nature Chemical Biology
2026-03-01
|
#cancer
#immunotherapy
#apoptosis
#autophagy
|
|
0
|
|
Causal modeling reveals cell-cell communication dynamics in the tumor microenvironment during anti-PD-1 therapy in breast cancer patients.
(academic.oup.com)
|
Qiu A
…
Lu X
Briefings in Bioinformatics
2026-03-01
|
#cancer
#immunotherapy
#single-cell
#causal inference
#cell-cell communication
|
|
0
|
|
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
(nature.com)
|
Gonzalez-Kozlova E
…
Gnjatic S
Nature Medicine
2026-03-01
|
#immunity
#antibody
#transcriptomics
#cancer
#immunotherapy
|
|
0
|
|
Clinical development of cancer vaccines.
(nature.com)
|
Haanen JB
…
Wu CJ
Nature Medicine
2026-03-01
|
#vaccination
#cancer
#clinical trial
#immunotherapy
#neoantigens
|